Several prominent foundation models are employed to enhance our understanding of high-throughput biological data, followed by a discussion on the application of prediction and generation models across ...
Fresenius Medical Care Corporation (FMS) target price: $26.77 (15.1% upside). Current price: $23.25. See our analyst rating, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results